Relapsed Acute Lymphoblastic Leukemia

Over the last decade, new therapeutic options and strategies have been developed for relapsed acute lymphoblastic leukemia (ALL) including immunotherapies and cellular therapies. It is imperative to understand how and when to use these newer approaches in relapsed ALL.